Skip to main content

Loading market data...

OHI

Omega Healthcare Investors, Inc.

NYSE • United states

$44.45

-$1.10

(-2.41%)

Source: Yahoo Finance · Quote time Oct 21, 2026 20:00 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

Omega Healthcare Investors, Inc. (OHI)

Unavailable

Quotes may be delayed

$13.47B

Market Cap

1,699,461

Volume

50.1

P/E Ratio

5.92%

Div Yield

Omega Healthcare Investors, Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 303 INTERNATIONAL CIRCLE,, HUNT VALLEY, MD
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

5 Oct 2026

Omega Healthcare Investors, Inc. reported Regulation FD disclosure

Omega Healthcare Investors, Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

1 Oct 2026

Omega Healthcare Investors, Inc. reported A director or senior management change or compensation event

Omega Healthcare Investors, Inc. filed an 8-K covering a director or senior management change or compensation event.

14 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Omega Healthcare Investors, Inc..

30 Jul 2026

Omega Healthcare Investors, Inc. filed Form 10-Q

Omega Healthcare Investors, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

30 Jul 2026

Omega Healthcare Investors, Inc. reported Operating or financial results

Omega Healthcare Investors, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$39.04M

Total assets (USD)$10.01B

Total liabilities (USD)$4.37B

Shareholders' equity (USD)$5.39B

Long-term debt (USD)$4.26B

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Real Estate

Company	Price	Market Cap
WELL - Welltower Inc.	$235.98 Yahoo Finance	$170.08B
PLD - Prologis, Inc.	$128.69 Yahoo Finance	$122.01B
BN - Brookfield Corporation	$37.54 Yahoo Finance	$92.00B
AMT - American Tower Corporation	$180.61 Yahoo Finance	$84.16B
BAM - Brookfield Asset Management Ltd.	$45.93 Yahoo Finance	$73.36B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$13.99M	$330.91M	$362.82M	$1.19	10-Q · 30 Jul 2026
Q1 2026	$6.66M	Unavailable	$151.05M	$0.47	10-Q · 29 Apr 2026
Q4 2025	$319.22M	Unavailable	−$424.74M	Unavailable	10-K · 9 Feb 2026
Q3 2025	$311.59M	Unavailable	$179.72M	$0.59	10-Q · 31 Oct 2025
Q2 2025	$282.51M	$281.24M	$136.60M	$0.46	10-Q · 1 Aug 2025
Q1 2025	$276.79M	Unavailable	$109.03M	$0.33	10-Q · 2 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Neutral

Target: $50.45

13.5% upside potential

📈

Strong Buy

Unavailable

👍

Buy

4

⏸️

Hold

5

📉

Sell

2

11 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 22 Oct 2026, 02:47 UTC Targets range 46.00–58.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

1

Oct 2026

Golem Lucas M.

CHIEF ACCOUNTING OFFICER

Grant or award

$39.37 per share

64 shares

1

Oct 2026

Golem Lucas M.

CHIEF ACCOUNTING OFFICER

Disposition to the company

$46.31 per share

3 shares

7

Aug 2026

Egbuonu-Davis Lisa

Director

Gift

Unavailable per share

5,131 shares

Top Shareholders

Vanguard Group Inc

42,160,010 shares

0.018% change

12/31/2025

Blackrock, Inc.

38,551,916 shares

3.63% change

6/30/2026

Vanguard Portfolio Management Llc

27,229,625 shares

0.393% change

6/30/2026

Cohen & Steers, Inc.

22,936,053 shares

91.492% change

6/30/2026

State Street Corp

14,527,955 shares

-0.311% change

6/30/2026

Vanguard Capital Management Llc

13,436,631 shares

1.53% change

6/30/2026

Geode Capital Management, Llc

9,141,024 shares

2.385% change

6/30/2026

Invesco Ltd.

5,889,795 shares

-0.561% change

6/30/2026

Bank Of New York Mellon Corp

5,772,439 shares

34.436% change

6/30/2026

Charles Schwab Investment Management Inc

4,818,440 shares

4.37% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 22 Oct 2026, 02:47 UTC· 5 hours ago

Research coverage and investment tools

Omega Healthcare Investors, Inc. (OHI) is a stock listed on the New York Stock Exchange in the United States, in the Real Estate sector (Real Estate Investment Trusts). Its last price was US$44.45 on 21 Oct 2026. That is 40% of the way from its 52-week low of US$39.26 to its 52-week high of US$52.39. It paid US$2.69 a share in dividends over the last 12 months, a dividend yield of 5.92%. The latest ex-dividend date on file is 3 Aug 2026. Its market capitalisation was US$13.47 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$13.99M	$330.91M	$362.82M	$1.19	—	2,365.9%	—	10-Q · 30 Jul 2026 (opens in a new tab)
Q1 2026	$6.66M	Unavailable	$151.05M	$0.47	—	—	—	10-Q · 29 Apr 2026 (opens in a new tab)
Q4 2025	$319.22M	Unavailable	−$424.74M	Unavailable	—	—	—	10-K · 9 Feb 2026 (opens in a new tab)
Q3 2025	$311.59M	Unavailable	$179.72M	$0.59	—	—	—	10-Q · 31 Oct 2025 (opens in a new tab)
Q2 2025	$282.51M	$281.24M	$136.60M	$0.46	—	99.6%	—	10-Q · 1 Aug 2025 (opens in a new tab)
Q1 2025	$276.79M	Unavailable	$109.03M	$0.33	—	—	—	10-Q · 2 May 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	7/29/2026	$0.83	$0.77	+7.8%
Mar 2026	4/28/2026	$0.82	$0.77	+6.5%
Dec 2025	2/4/2026	$0.80	$0.75	+6.7%
Sep 2025	10/30/2025	$0.79	$0.73	+8.2%

Cash and equivalents: $39.04M
Total assets: $10.01B
Total liabilities: $4.37B
Shareholders' equity: $5.39B
Long-term debt: $4.26B

8-K · 5 Oct 2026

Omega Healthcare Investors, Inc. reported Regulation FD disclosure (opens in a new tab)

Omega Healthcare Investors, Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.
8-K · 1 Oct 2026 · Management change

Omega Healthcare Investors, Inc. reported A director or senior management change or compensation event (opens in a new tab)

Omega Healthcare Investors, Inc. filed an 8-K covering a director or senior management change or compensation event.
SCHEDULE 13G · 14 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Omega Healthcare Investors, Inc..
10-Q · 30 Jul 2026

Omega Healthcare Investors, Inc. filed Form 10-Q (opens in a new tab)

Omega Healthcare Investors, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 30 Jul 2026

Omega Healthcare Investors, Inc. reported Operating or financial results (opens in a new tab)

Omega Healthcare Investors, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

Insider	Date	Transaction	Shares	Average price	Filing
Golem Lucas M. CHIEF ACCOUNTING OFFICER	1 Oct 2026	Grant or award (A)	+64	$39.37	Form 4 (opens in a new tab)
Golem Lucas M. CHIEF ACCOUNTING OFFICER	1 Oct 2026	Disposition to the company (D)	−3	$46.31	Form 4 (opens in a new tab)
Egbuonu-Davis Lisa Director	7 Aug 2026	Gift (G)	−5,131	—	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Vanguard Group Inc	12/31/2025	42,160,010	0.018%
Blackrock, Inc.	6/30/2026	38,551,916	3.63%
Vanguard Portfolio Management Llc	6/30/2026	27,229,625	0.393%
Cohen & Steers, Inc.	6/30/2026	22,936,053	91.492%
State Street Corp	6/30/2026	14,527,955	-0.311%
Vanguard Capital Management Llc	6/30/2026	13,436,631	1.53%
Geode Capital Management, Llc	6/30/2026	9,141,024	2.385%
Invesco Ltd.	6/30/2026	5,889,795	-0.561%
Bank Of New York Mellon Corp	6/30/2026	5,772,439	34.436%
Charles Schwab Investment Management Inc	6/30/2026	4,818,440	4.37%

Previous close: 45.55 USD
Day range: 44.36 – 45.63 USD
52-week range: 39.26 – 52.39 USD
Volume: 1,699,461
Market cap: $13.47B
Average volume: 1,826,232
P/E ratio: 50.1
EPS (FY 2025, diluted): 1.94 USD
Dividends (last 12 months): 2.69 USD
Dividend yield: 5.92%
Ex-dividend date: 3 Aug 2026
Shares outstanding: 303.01M
Beta (5Y monthly): 0.56

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 20:00 UTC· 11 hours ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:20 UTC· 1 hour ago

Dividends: Yahoo Finance dividend history (opens in a new tab) Observed 22 Oct 2026, 06:20 UTC· 1 hour ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding. What dividend yield leaves out: dividend yield vs total return

This research is not available for OHI yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.